Authorization

SHAREHOLDER ALERT: WeissLaw LLP Investigates Pandion Therapeutics, Inc.

NEW YORK, Feb. 25, 2021 /PRNewswire/ --A WeissLaw LLPA is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pandion Therapeutics, Inc. ("Pandion" or the "Company") (NASDAQ: PAND) in connection withA the proposed all-cash acquisition of the Company by Merck Sharp & Dohme Corp. (NYSE: MRK).A  Under the terms of the merger agreement, Pandion shareholders will receive $60.00 in cash for each share of PandionA common stock that they own.A  The transaction is valued at approximately $1.85 billion.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Pandion Therapeutics, Inc.
If you own PAND shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:https://www.weisslawllp.com/PAND/Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NYA  10036
(212)A 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2021    »
ПнВтСрЧтПтСбВс
 1234
567891011
12131415161718
19202122232425
2627282930